Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+2.37M
-
Total reported value, excl. options
-
$214M
-
Value change
-
+$4.8M
-
Put/Call ratio
-
0.65
-
Number of buys
-
54
-
Number of sells
-
-44
-
Price
-
$1.99
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2020
128 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2020.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 363M outstanding shares and own 29.51% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60.2M shares), FMR LLC (11M shares), Ulys, L.L.C. (4.32M shares), BlackRock Inc. (4.22M shares), VANGUARD GROUP INC (2.48M shares), NEA Management Company, LLC (2.38M shares), MORGAN STANLEY (2.02M shares), RENAISSANCE TECHNOLOGIES LLC (1.88M shares), FEDERATED HERMES, INC. (1.71M shares), and ACADIAN ASSET MANAGEMENT LLC (1.66M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.